Equillium, Inc. Common Stock

EQNASDAQ • USD
1.25 USD
↗ 0.02 (1.63%)AT CLOSE (03:59 PM EDT)
1.32
↗ 0.06 (5.20%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
1.32
↗ 0.06 (5.20%)
🔴Market: CLOSED

Equillium, Inc. Common Stock (EQ) is currently trading at $1.24. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 26, 2026.

Open?$1.20
High?$1.25
Low?$1.17
Prev. Close?$1.23
Volume?210.8K
Avg. Volume?730.8K
VWAP?$1.21
Rel. Volume?0.29x
Bid / Ask
Bid?$1.27 × 100
Ask?$1.32 × 1.5K
Spread?$0.05
Midpoint?$1.30
Valuation & Ratios
Market Cap?79.3M
Shares Out?63.4M
Float?44.8M
Float %?70.8%
P/E Ratio?N/A
P/B Ratio?1.41
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Employees
14
Market Cap
78.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-10-12
Address
2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
Phone: (858) 412-5302
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?12.60Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.63%High
Short Interest?5.7M
Days to Cover?11.0
Free Float44.8M
Avg Daily Volume515.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?23.40Strong
Quick Ratio?23.40Strong
Cash Ratio?23.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
89
1.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-32.1%WEAK▾
ROA?
S&P
3
-30.7%WEAK▾
Cash Flow & Enterprise
FCF?$-20090000
Enterprise Value?$22.1M
Fundamentals ratios updated end of day